Sexually transmitted diseases control in developing countries. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Sexually transmitted diseases control in developing countries.

Genitourin Med. 1996 Apr;72(2):83-8. Unique Identifier : AIDSLINE MED/96273392
Adler MW; Academic Department of Genitourinary Medicine, Mortimer Market; Centre, London, UK.

Abstract: Sexually transmitted diseases (STDs) are a major public health problem now compounded by the advent of AIDS and HIV infection. The size of the problem represented by STDs and HIV is unknown however it is estimated that there are 333 million new cases of STD per annum and currently 15-20 million people infected worldwide with HIV. Control programmes for STDs must prevent the acquisition of STDs, their complications and sequelae and interrupt and reduce transmission. They can also reduce the incidence of HIV infection. Such programmes must place emphasis on health education, condom usage, altering health seeking behaviour and providing case management. The syndromic approach currently offers the most realistic, and cost effective, way in which to treat patients.
Keywords: Adolescence Adult Algorithms Case Management Condoms/UTILIZATION *Developing Countries Female Health Education Human Male Models, Organizational Patient Acceptance of Health Care Prevalence Sexually Transmitted Diseases/EPIDEMIOLOGY/*PREVENTION & CONTROL JOURNAL ARTICLEKWDadolescenceadultalgorithmscasemanagementcondoms/utilizationKWDdevelopingcountriesfemalehealtheducationhumanmalemodels,organizationalpatientacceptanceofhealthcareprevalencesexuallytransmitteddiseases/epidemiology/KWDprevention&controljournalarticle
961130
M96B1817

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .